Peer review reports
From: Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3
Original Submission |
13 Jan 2022 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
28 Feb 2022 |
Reviewed |
Reviewer Report
|
8 Mar 2022 |
Reviewed |
Reviewer Report
|
20 Apr 2022 |
Author responded |
Author comments - Xun Cai
|
Resubmission - Version 4 |
20 Apr 2022 |
Submitted |
Manuscript version 4
|
26 Apr 2022 |
Author responded |
Author comments - Xun Cai
|
Resubmission - Version 5 |
26 Apr 2022 |
Submitted |
Manuscript version 5
|
2 May 2022 |
Author responded |
Author comments - Xun Cai
|
Resubmission - Version 6 |
2 May 2022 |
Submitted |
Manuscript version 6
|
31 May 2022 |
Reviewed |
Reviewer Report
|
Resubmission - Version 7 |
|
Submitted |
Manuscript version 7
|
Publishing |
23 Jun 2022 |
Editorially accepted |
|
9 Jul 2022 |
Article published |
10.1186/s12885-022-09828-2
|
Learn about peer review